Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer. (Charles Mullighan, MD)
Read More...
[Source: St. Jude Children's Research Hospital - Latest News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment